Brown Foundation Award for Excellence in Oncology Nursing presented to Jacqueline B. Broadway-Duren, Ph.D., D.N.P.
HOUSTON ¨D Âé¶¹Ó³» MD Anderson Cancer Center has named Jacqueline B. Broadway-Duren, Ph.D., D.N.P., as the recipient of the 2022 Brown Foundation Award for Excellence in Oncology Nursing. The Brown Foundation Award is the institution¡¯s highest individual nursing honor, recognizing excellence in all aspects of oncology nursing, including superior patient care and adherence to the utmost standards in clinical treatment.

MD Anderson Research Highlights for November 30, 2022
Âé¶¹Ó³» MD Anderson Cancer Center¡¯s Research Highlights provides a glimpse into recent basic, translational and clinical cancer...
A Conversation With a Living Legend? San Antonio honors Nobel Laureate, raises funds for James P. Allison Institute
More than $650,000 raised at 11th annual luncheon?
HOUSTON ¨D Âé¶¹Ó³» MD Anderson Cancer Center¡¯s signature A Conversation...
MD Anderson Research Highlights for November 16, 2022
Âé¶¹Ó³» MD Anderson Cancer Center¡¯s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD?Anderson experts. Current advances include a promising targeted therapy combination for patients with relapsed/refractory acute myeloid leukemia (AML), a link between the gut microbiome and therapy-related neutropenic fever, a novel therapeutic target for immunotherapy-related...

MD Anderson and Exscientia launch strategic collaboration to leverage AI in developing novel oncology treatments
Âé¶¹Ó³» MD Anderson Cancer Center and Exscientia plc today announced a strategic collaboration to align the drug discovery...
Eyal Gottlieb, Ph.D., to join MD Anderson as Vice President for Research
Âé¶¹Ó³» MD Anderson Cancer Center today announced that Eyal Gottlieb, Ph.D., has been named the institution¡¯s vice president...
Nanotechnology platform enables immune conversion of cancer cells, sensitizing them to immunotherapy
A team of researchers at Âé¶¹Ó³» MD Anderson Cancer Center has developed a nanotechnology platform that can change the way...
MD Anderson Research Highlights: SITC 2022 Special Edition
ABSTRACTS:?374,?568,?590,?657,?659,?782
Âé¶¹Ó³»?MD Anderson?Cancer Center¡¯s...
Shorter course of radiation therapy yields comparable results for patients with non-metastatic soft tissue sarcoma
Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment...
MD Anderson Research Highlights for November 3, 2022
Âé¶¹Ó³» MD Anderson Cancer Center¡¯s Research Highlights provides a glimpse into recent basic, translational and clinical cancer...
Cancer survivors, supporters rally for in-person return of MD Anderson¡¯s Boot Walk to End Cancer?
1.2-mile walk, which participants can also do virtually, raises funds for cancer research around the globe
HOUSTON ¨D Thousands are...
Hormone therapy could lower risk of immunotherapy-associated myocarditis in women
A new preclinical study from researchers at Âé¶¹Ó³» MD?Anderson Cancer Center and the University of California San Francisco...